NTG CLARITY NETWORKS INC (NCI.CA) Fundamental Analysis & Valuation
TSX-V:NCI • CA62940V2030
1.03 CAD
+0.01 (+0.98%)
Last: Mar 5, 2026, 07:00 PM
This NCI.CA fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
We assign a fundamental rating of 6 out of 10 to NCI. NCI was compared to 70 industry peers in the Software industry. NCI has an average financial health and profitability rating. NCI is growing strongly while it is still valued neutral. This is a good combination! These ratings could make NCI a good candidate for growth investing.
1. NCI.CA Profitability Analysis
1.1 Basic Checks
- In the past year NCI was profitable.
- In the past year NCI has reported a negative cash flow from operations.
- NCI had positive earnings in 4 of the past 5 years.
- NCI had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- NCI's Return On Assets of 17.08% is amongst the best of the industry. NCI outperforms 91.43% of its industry peers.
- The Return On Equity of NCI (28.01%) is better than 92.86% of its industry peers.
- NCI has a better Return On Invested Capital (23.79%) than 95.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.08% | ||
| ROE | 28.01% | ||
| ROIC | 23.79% |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- Looking at the Profit Margin, with a value of 9.85%, NCI belongs to the top of the industry, outperforming 82.86% of the companies in the same industry.
- In the last couple of years the Profit Margin of NCI has grown nicely.
- With a decent Operating Margin value of 13.86%, NCI is doing good in the industry, outperforming 78.57% of the companies in the same industry.
- In the last couple of years the Operating Margin of NCI has declined.
- NCI's Gross Margin of 35.76% is on the low side compared to the rest of the industry. NCI is outperformed by 61.43% of its industry peers.
- NCI's Gross Margin has improved in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 13.86% | ||
| PM (TTM) | 9.85% | ||
| GM | 35.76% |
OM growth 3Y-3.27%
OM growth 5YN/A
PM growth 3Y14.92%
PM growth 5YN/A
GM growth 3Y-12.47%
GM growth 5Y7.3%
2. NCI.CA Health Analysis
2.1 Basic Checks
- NCI has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
- The number of shares outstanding for NCI has been increased compared to 1 year ago.
- The number of shares outstanding for NCI has been increased compared to 5 years ago.
- Compared to 1 year ago, NCI has an improved debt to assets ratio.
2.2 Solvency
- NCI has an Altman-Z score of 4.77. This indicates that NCI is financially healthy and has little risk of bankruptcy at the moment.
- NCI has a Altman-Z score of 4.77. This is in the better half of the industry: NCI outperforms 77.14% of its industry peers.
- A Debt/Equity ratio of 0.19 indicates that NCI is not too dependend on debt financing.
- Looking at the Debt to Equity ratio, with a value of 0.19, NCI is in line with its industry, outperforming 55.71% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | N/A | ||
| Altman-Z | 4.77 |
ROIC/WACC2.33
WACC10.23%
2.3 Liquidity
- NCI has a Current Ratio of 3.13. This indicates that NCI is financially healthy and has no problem in meeting its short term obligations.
- NCI has a better Current ratio (3.13) than 77.14% of its industry peers.
- NCI has a Quick Ratio of 3.13. This indicates that NCI is financially healthy and has no problem in meeting its short term obligations.
- NCI's Quick ratio of 3.13 is fine compared to the rest of the industry. NCI outperforms 78.57% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.13 | ||
| Quick Ratio | 3.13 |
3. NCI.CA Growth Analysis
3.1 Past
- NCI shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 15.26%, which is quite good.
- Measured over the past years, NCI shows a very strong growth in Earnings Per Share. The EPS has been growing by 68.04% on average per year.
- NCI shows a strong growth in Revenue. In the last year, the Revenue has grown by 62.61%.
- NCI shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 45.43% yearly.
EPS 1Y (TTM)15.26%
EPS 3Y68.04%
EPS 5YN/A
EPS Q2Q%-15.85%
Revenue 1Y (TTM)62.61%
Revenue growth 3Y67.72%
Revenue growth 5Y45.43%
Sales Q2Q%42.22%
3.2 Future
- NCI is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -1.23% yearly.
- Based on estimates for the next years, NCI will show a very strong growth in Revenue. The Revenue will grow by 31.31% on average per year.
EPS Next Y-34.96%
EPS Next 2Y-1.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year46.45%
Revenue Next 2Y31.31%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
- Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
4. NCI.CA Valuation Analysis
4.1 Price/Earnings Ratio
- With a Price/Earnings ratio of 7.36, the valuation of NCI can be described as very cheap.
- Based on the Price/Earnings ratio, NCI is valued cheaply inside the industry as 87.14% of the companies are valued more expensively.
- The average S&P500 Price/Earnings ratio is at 26.74. NCI is valued rather cheaply when compared to this.
- With a Price/Forward Earnings ratio of 5.56, the valuation of NCI can be described as very cheap.
- Based on the Price/Forward Earnings ratio, NCI is valued cheaply inside the industry as 87.14% of the companies are valued more expensively.
- NCI's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 24.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.36 | ||
| Fwd PE | 5.56 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of NCI indicates a rather cheap valuation: NCI is cheaper than 88.57% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 3.95 |
4.3 Compensation for Growth
- NCI has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-1.23%
EPS Next 3YN/A
5. NCI.CA Dividend Analysis
5.1 Amount
- No dividends for NCI!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
NCI.CA Fundamentals: All Metrics, Ratios and Statistics
TSX-V:NCI (3/5/2026, 7:00:00 PM)
1.03
+0.01 (+0.98%)
Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-12 2025-11-12/amc
Earnings (Next)N/A N/A
Inst Owners0.35%
Inst Owner ChangeN/A
Ins Owners24.52%
Ins Owner ChangeN/A
Market Cap49.20M
Revenue(TTM)76.65M
Net Income(TTM)7.55M
Analysts84
Price Target3.67 (256.31%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-59.73%
Min EPS beat(2)-85.29%
Max EPS beat(2)-34.18%
EPS beat(4)1
Avg EPS beat(4)-14.44%
Min EPS beat(4)-85.29%
Max EPS beat(4)94.17%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)-2.48%
Min Revenue beat(2)-5.69%
Max Revenue beat(2)0.73%
Revenue beat(4)3
Avg Revenue beat(4)1.13%
Min Revenue beat(4)-5.69%
Max Revenue beat(4)8.23%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-9.24%
PT rev (3m)-9.24%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-33.33%
EPS NY rev (1m)0%
EPS NY rev (3m)-43.75%
Revenue NQ rev (1m)-1.53%
Revenue NQ rev (3m)-1.38%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)0.61%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 7.36 | ||
| Fwd PE | 5.56 | ||
| P/S | 0.64 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 1.82 | ||
| P/tB | 2.1 | ||
| EV/EBITDA | 3.95 |
EPS(TTM)0.14
EY13.59%
EPS(NY)0.19
Fwd EY18%
FCF(TTM)-0.13
FCFYN/A
OCF(TTM)-0.1
OCFYN/A
SpS1.6
BVpS0.56
TBVpS0.49
PEG (NY)N/A
PEG (5Y)N/A
Graham Number1.33
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.08% | ||
| ROE | 28.01% | ||
| ROCE | 33.04% | ||
| ROIC | 23.79% | ||
| ROICexc | 29.91% | ||
| ROICexgc | 34.7% | ||
| OM | 13.86% | ||
| PM (TTM) | 9.85% | ||
| GM | 35.76% | ||
| FCFM | N/A |
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.27%
OM growth 5YN/A
PM growth 3Y14.92%
PM growth 5YN/A
GM growth 3Y-12.47%
GM growth 5Y7.3%
F-Score5
Asset Turnover1.73
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.19 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 0.43 | ||
| Cap/Depr | 101.9% | ||
| Cap/Sales | 1.94% | ||
| Interest Coverage | 31.2 | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 3.13 | ||
| Quick Ratio | 3.13 | ||
| Altman-Z | 4.77 |
F-Score5
WACC10.23%
ROIC/WACC2.33
Cap/Depr(3y)274.99%
Cap/Depr(5y)720.23%
Cap/Sales(3y)6.12%
Cap/Sales(5y)8.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)15.26%
EPS 3Y68.04%
EPS 5YN/A
EPS Q2Q%-15.85%
EPS Next Y-34.96%
EPS Next 2Y-1.23%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)62.61%
Revenue growth 3Y67.72%
Revenue growth 5Y45.43%
Sales Q2Q%42.22%
Revenue Next Year46.45%
Revenue Next 2Y31.31%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y53.89%
EBIT growth 3Y62.24%
EBIT growth 5YN/A
EBIT Next Year19.12%
EBIT Next 3Y25.69%
EBIT Next 5YN/A
FCF growth 1Y-1129.52%
FCF growth 3Y85.08%
FCF growth 5YN/A
OCF growth 1Y-287.68%
OCF growth 3Y12.61%
OCF growth 5Y234.98%
NTG CLARITY NETWORKS INC / NCI.CA FAQ
What is the fundamental rating for NCI stock?
ChartMill assigns a fundamental rating of 6 / 10 to NCI.CA.
What is the valuation status for NCI stock?
ChartMill assigns a valuation rating of 6 / 10 to NTG CLARITY NETWORKS INC (NCI.CA). This can be considered as Fairly Valued.
Can you provide the profitability details for NTG CLARITY NETWORKS INC?
NTG CLARITY NETWORKS INC (NCI.CA) has a profitability rating of 6 / 10.
What is the expected EPS growth for NTG CLARITY NETWORKS INC (NCI.CA) stock?
The Earnings per Share (EPS) of NTG CLARITY NETWORKS INC (NCI.CA) is expected to decline by -34.96% in the next year.